Affinity Molecules offers expertise and high quality services and products for research and therapeutics development. Major areas of our expertise include cell line generation for biologics production, antibody and Fab fragment expression, purification and assay development. Our team of well-trained and highly experienced scientists provides assistance with design and scientific support of customer’s projects.

Great news – the Affinity Molecules team was recently awarded the NIH Phase I grant award “Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes”, Project Number 1R43TR003596-01.

Cell line generation services

YOUR CELL LINE:

Affinity Molecules offers custom cell line generation services that include a full spectrum of steps from generation of expression constructs to creation of manufacturing-grade, GMP-amenable CHO-based cell lines for production of antibodies and other biologics.

Protein production

YOUR PROTEIN:

Affinity Molecules offers protein and antibody production and purification services, including antibody-related molecular therapeutics for pre-clinical studies. We use a wide spectrum of expression and purification approaches that can be tailored for your specific needs.

Biological assay development services

YOUR ASSAY:

Affinity Molecules offers customized biological assay development including ELISA, flow cytometry, plasmon resonance and cell-based assays. Our experts provide assistance with assay design, optimization, validation and development of Standard Operational Procedures (SOP).

Mycoplasma detection services

YOUR ASSURANCE:

Affinity Molecules offers mycoplasma detection services for detection of common mycoplasma species. PCR-based assay protocol provides fast and reliable detection of contamination directly in culture medium. Mycoplasma testing is now recommended by the National Institute of Health to ensure rigor and reproducibility of NIH-funded research.